Biotech Earnings Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 31, 9:01AM CDT
Following solid results from Amgen, among others, these biotech ETFs could be ones to watch.
The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary
Zacks Equity Research - ZACKS - Thu Jul 17, 9:00AM CDT
Thanks to Yellen and her comments, these high growth ETFs could be in focus.
The Zacks Analyst Blog Highlights:Vertex Pharmaceuticals, Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, First Trust NYSE Arca Biotechnology Index Fund, PowerShares Dynamic Biotechnology & Genome Portfolio and SPDR S&P Biotech ETF
PR Newswire - Thu Jun 26, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Vertex Pharmaceuticals (Nasdaq:VRTX-Free Report), Market Vectors Biotech ETF (AMEX:BBH-Free Report), iShares Nasdaq Biotechnology ETF (Nasdaq:IBB-Free Report), First Trust NYSE Arca Biotechnology Index Fund (AMEX:FBT-Free Report), PowerShares Dynamic Biotechnology & Genome Portfolio (AMEX
Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
Two Biotech ETFs Surge on Idenix-Merck Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jun 10, 1:00PM CDT
Idenix Pharmaceuticals pushes these two biotech ETFs higher ahead of the rivals on Merck buyout.
A Comprehensive Guide to Biotech ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Fri May 30, 7:00AM CDT
Despite recent volatility in the space, the longer-term fundamentals remain attractive.
Biotech HOLDRs Trust Shares Down 10.5% Since SmarTrend's Sell Call (BBH)
Comtex SmarTrend(R) - Mon Mar 31, 9:27AM CDT
SmarTrend identified a Downtrend for Biotech HOLDRs Trust (AMEX:BBH) on March 7th, 2014 at $100.08. In approximately 3 weeks, Biotech HOLDRs Trust has returned 10.52% as of today's recent price of $89.55.
3 ETFs Tumble Most on Biotech Sell-off - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Mon Mar 24, 1:00PM CDT
The terrible trading in the biotech stock world sent these ETFs into deep red in Friday session.
The Guide to Surging Biotech ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 11:00AM CST
Investors should not ignore this high growth sector that continues to deliver strong performance
Intercept Pharma (ICPT) Pushes SPDR Biotech ETF Ahead of Rivals - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Fri Jan 10, 6:54AM CST
Intercept Pharma added nearly 300% on the session, but not all biotech ETFs benefited equally.
The Best ETFs of 2013
Dan Caplinger, The Motley Fool - Motley Fool - Fri Dec 20, 4:55PM CST
Exchange-traded funds have maintained their immense popularity throughout the bull market as an increasing number of investors look at ETFs as a flexible, low-cost alternative to actively managed mutual funds. With thousands of different ETFs to...
How to Know if You Are Really a 'Value' Investor
at The Street - Wed Dec 11, 10:32AM CST
How many of us truly have the stomach or temperament for investing in the most hated of asset classes?